User profiles for "author:Jonas Mattsson"

Jonas Mattsson

Professor of Medicine, University of Toronto
Verified email at uhn.ca
Cited by 9612

[HTML][HTML] Graft failure after allogeneic hematopoietic cell transplantation

J Mattsson, O Ringdén, R Storb - Biology of blood and marrow …, 2008 - Elsevier
Graft failure is a significant complication following allogeneic hematopoietic cell
transplantation (alloHCT). It may result from rejection caused by recipient T cells, natural …

[HTML][HTML] Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment

E Schoutrop, L Moyano-Galceran, S Lheureux… - Seminars in cancer …, 2022 - Elsevier
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the
ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the …

Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors

A Schurich, I Magalhaes, J Mattsson - Immunotherapy, 2019 - Future Medicine
The field of immunometabolism has attracted growing attention as an area at the heart of
immune regulation. Upon activation, T cells undergo significant metabolic changes allowing …

[HTML][HTML] Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

M Uhlin, H Wikell, M Sundin, O Blennow… - …, 2014 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …

[HTML][HTML] Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study

M Remberger, M Ackefors, S Berglund… - Biology of Blood and …, 2011 - Elsevier
We analyzed the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) over
the past 2 decades. Between 1992 and 2009, 953 patients were treated with HSCT, mainly …

RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT …

P Ljungman, J Aschan, I Lewensohn-Fuchs… - …, 1998 - journals.lww.com
RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS... :
Transplantation RESULTS OF DIFFERENT STRATEGIES FOR REDUCING …

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease

M Uhlin, J Gertow, M Uzunel, M Okas… - Clinical Infectious …, 2012 - academic.oup.com
Background. Viral infections are major complications after allogeneic hematopoietic stem
cell transplantation (HSCT). During posttransplant immunosuppression the regular T-cell …

[HTML][HTML] Effect of total nucleated and CD34+ cell dose on outcome after allogeneic hematopoietic stem cell transplantation

M Remberger, J Törlén, O Ringdén, M Engström… - Biology of Blood and …, 2015 - Elsevier
During more recent years only few studies have analyzed the effect of total nucleated cell
(TNC) and CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT). A …

[HTML][HTML] A new member of the family of di-iron carboxylate proteins

P Stenmark, J Grunler, J Mattsson, PJ Sindelar… - Journal of Biological …, 2001 - ASBMB
Ubiquinone (UQ) is an essential cofactor for respiratory metabolism. In yeast, mutation of
theCOQ7 gene results in the absence of UQ biosynthesis and demonstrates a role for this …

Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation

M Remberger, BM Svahn, J Mattsson… - Transplantation, 2004 - journals.lww.com
Background. Thymoglobulin given before allo-hematopoietic stem-cell transplantation
(HSCT) from unrelated donors reduces acute graft-versus-host disease (GvHD), but the …